Recent Advances in Biochemical Pathways : Implication for Drug Development and Therapeutics A Review

Mohammed Ibrahim Anwer; Noori Taha Khalaf; Hiba Rafid Kamal; Sana  Abdalelah Abdalmawjood

doi:10.61132/obat.v3i4.1531

Authors

Mohammed Ibrahim Anwer University of Mosul
Noori Taha Khalaf University of Telafer
Hiba Rafid Kamal University of Mosul
Sana Abdalelah Abdalmawjood University of Mosul

DOI:

https://doi.org/10.61132/obat.v3i4.1531

Keywords:

Biochemical Pathways, Metabolic Pathways, Signaling Pathways, Systems Biology, Single-cell Transcriptomics

Abstract

Biochemical pathways are the complex pathways of chemical reactions vital to maintain cellular homeostasis, control metabolism and modulate responses to physiological stimuli. Recent developments in the omics technologies, gene editing tools, and systems biology have significantly deepened our understanding of these pathways, changing the scientific paradigm from linear reactions to complex and interrelated regulatory networks. This review examines the changing face of metabolic and signaling pathways including but not limited to glycolysis, TCA cycle, MAPK, PI3K/AKT and JAK/STAT and their role in health and disease. Particular attention is paid to pathway analysis innovations, including CRISPR/Cas9, single-cell and spatial transcriptomics, and computational modelling and their revolutionary effect on discovery of new drug targets and pathway specific therapeutics. In reviewing the most recent advances in cancer metabolism, immune signaling, and cross-pathway interactions, this paper emphasizes the translational promise of pathway-centric research for personalized medicine, especially in oncology, neurodegeneration, cardiovascular, and autoimmune diseases. The review attempts to bridge basic biochemical research with clinical applications, and provides a window into the manner in which pathway-based interventions are influencing the future of precision therapeutics.

Downloads

Download data is not yet available.

References

An, S. M., Ding, Q., Zhang, J., Xie, J., & Li, L. (2014). Targeting stem cell signaling pathways for drug discovery: Advances in the Notch and Wnt pathways. Science China Life Sciences, 57, 575–580. https://doi.org/10.1007/s11427-014-4669-3

Arteaga, C. L., & Baselga, J. (2003). Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: Implications for drug development and practice. Clinical Cancer Research, 9(5), 1579–1589.

Bhatti, G. K., Khullar, N., Sidhu, I. S., Navik, U. S., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2021). Emerging role of non‐coding RNA in health and disease. Metabolic Brain Disease, 36, 1119–1134. https://doi.org/10.1007/s11011-021-00698-5

Carr, A. (2003). Toxicity of antiretroviral therapy and implications for drug development. Nature Reviews Drug Discovery, 2(8), 624–634. https://doi.org/10.1038/nrd1151

Dang, Q., Li, B., Jin, B., Ye, Z., Lou, X., Wang, T., ... & Xu, X. (2024). Cancer immunometabolism: Advent, challenges, and perspective. Molecular Cancer, 23(1), 72. https://doi.org/10.1186/s12943-024-02057-3

De, A. (2011). Wnt/Ca2+ signaling pathway: A brief overview. Acta Biochimica et Biophysica Sinica, 43(10), 745–756. https://doi.org/10.1093/abbs/gmr079

Debnath, M., Prasad, G. B., & Bisen, P. S. (2010). Omics technology. In Molecular Diagnostics: Promises and Possibilities (pp. 11–31). https://doi.org/10.1007/978-81-8489-396-2_2

Deville, Y., Gilbert, D., Van Helden, J., & Wodak, S. J. (2003). An overview of data models for the analysis of biochemical pathways. Briefings in Bioinformatics, 4(3), 246–259. https://doi.org/10.1093/bib/4.3.246

Giannone, G., Ghisoni, E., Genta, S., Scotto, G., Tuninetti, V., Turinetto, M., & Valabrega, G. (2020). Immuno-metabolism and microenvironment in cancer: Key players for immunotherapy. International Journal of Molecular Sciences, 21(12), 4414. https://doi.org/10.3390/ijms21124414

Ginsburg, G. S., Konstance, R. P., Allsbrook, J. S., & Schulman, K. A. (2005). Implications of pharmacogenomics for drug development and clinical practice. Archives of Internal Medicine, 165(20), 2331–2336. https://doi.org/10.1001/archinte.165.20.2331

Grainger, S., & Willert, K. (2018). Mechanisms of Wnt signaling and control. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 10(5), e1422. https://doi.org/10.1002/wsbm.1422

Hayat, R., Manzoor, M., & Hussain, A. (2022). Wnt signaling pathway: A comprehensive review. Cell Biology International, 46(6), 863–877. https://doi.org/10.1002/cbin.11801

Hombach, S., & Kretz, M. (2016). Non-coding RNAs: Classification, biology and functioning. In Non-Coding RNAs in Colorectal Cancer (pp. 3–17). https://doi.org/10.1007/978-3-319-42059-2_1

Horgan, R. P., & Kenny, L. C. (2011). 'Omic' technologies: Genomics, transcriptomics, proteomics and metabolomics. The Obstetrician & Gynaecologist, 13(3), 189–195. https://doi.org/10.1576/toag.13.3.189.27672

Janhunen, S., & Ahtee, L. (2007). Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development. Neuroscience & Biobehavioral Reviews, 31(3), 287–314. https://doi.org/10.1016/j.neubiorev.2006.08.003

Katoh, M., & Katoh, M. (2007). WNT signaling pathway and stem cell signaling network. Clinical Cancer Research, 13(14), 4042–4045. https://doi.org/10.1158/1078-0432.CCR-07-0493

McCarthy, A. (2018). Pharmacogenetics: Implications for drug development, patients and society. In Reconfiguring Nature (2004) (pp. 83–95). Routledge.

Michal, G., & Schomburg, D. (Eds.). (2012). Biochemical pathways: An atlas of biochemistry and molecular biology. John Wiley & Sons.

Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Ranjbar, A., ... & Sethi, G. (2021). Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? Cancer Letters, 509, 63–80. https://doi.org/10.1016/j.canlet.2021.03.005

Molehin, O. R., Fakayode, A. E., Olaoye, A. B., Teibo, J. O., & Adeola, O. A. (2024). Biochemical pathways involved in diabetes mellitus. In Biochemical Immunology of Diabetes and Associated Complications (pp. 75–100). Academic Press. https://doi.org/10.1016/B978-0-443-12211-2.00006-5

Patil, V. S., Zhou, R., & Rana, T. M. (2014). Gene regulation by non-coding RNAs. Critical Reviews in Biochemistry and Molecular Biology, 49(1), 16–32. https://doi.org/10.3109/10409238.2013.857291

Peschansky, V. J., & Wahlestedt, C. (2014). Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics, 9(1), 3–12. https://doi.org/10.4161/epi.26892

Rim, E. Y., Clevers, H., & Nusse, R. (2022). The Wnt pathway: From signaling mechanisms to synthetic modulators. Annual Review of Biochemistry, 91, 571–598. https://doi.org/10.1146/annurev-biochem-051320-122630

Slack, F. J., & Chinnaiyan, A. M. (2019). The role of non-coding RNAs in oncology. Cell, 179(5), 1033–1055. https://doi.org/10.1016/j.cell.2019.10.017

Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E., Jr. (2004). Trends in antimicrobial drug development: Implications for the future. Clinical Infectious Diseases, 38(9), 1279–1286. https://doi.org/10.1086/420937

Statello, L., Guo, C. J., Chen, L. L., & Huarte, M. (2021). Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology, 22(2), 96–118. https://doi.org/10.1038/s41580-020-00315-9

Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M., & Mattick, J. S. (2010). Non‐coding RNAs: Regulators of disease. The Journal of Pathology, 220(2), 126–139. https://doi.org/10.1002/path.2638

Yang, J. X., Rastetter, R. H., & Wilhelm, D. (2016). Non-coding RNAs: An introduction. In Non-coding RNA and the Reproductive System (pp. 13–32). https://doi.org/10.1007/978-3-319-42059-2_2

Zhou, S. F., Liu, J. P., & Lai, X. S. (2009). Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development. Current Medicinal Chemistry, 16(21), 2661–2805. https://doi.org/10.2174/092986709788682313